Skip to main content

Table 3 Treatments before and after first consultation with diagnosis of interest

From: The course of primary progressive aphasia diagnosis: a cross-sectional study

  Before first consultation with diagnosis of interest After first consultation with diagnosis of interest  
n (%) n (%) p-value
PPA patients
Pharmacological treatments
  Antidepressant 330 (20.4) 629 (38.8) <.001
  Anxiolytic 130 (8.0) 237 (14.6) <.001
  Hypnotic 64 (4.0) 94 (5.8) <.001
  Neuroleptic 29 (1.8) 116 (7.2) <.001
  NMDA antagonist 77 (4.8) 306 (18.9) <.001
  ChEI 144 (8.9) 426 (26.3) <.001
Non-pharmacological treatments
  Day hospital 24 (1.5) 158 (9.8) <.001
  Speech and language therapist (SLT) 365 (22.7) 1060 (66.0) <.001
  Psychologist 66 (4.1) 130 (8.1) <.001
  Kinesiologist 35 (2.2) 169 (10.5) <.001
  Occupational therapist 17 (1.1) 50 (3.1) <.001
  Stakeholder group 24 (1.5) 84 (5.2) <.001
AD patients
Pharmacological treatments
  Antidepressant 10,261 (24.1) 16,528 (38.8) <.001
  Anxiolytic 5226 (12.3) 8626 (20.3) <.001
  Hypnotic 2375 (5.6) 3380 (7.9) <.001
  Neuroleptic 1359 (3.2) 3943 (9.3) <.001
  NMDA antagonist 1801 (4.2) 11,670 (27.4) <.001
  ChEI 5967 (14.0) 24,927 (58.6) <.001
Non-pharmacological treatments
  Day hospital 628 (1.5) 5272 (12.7) <.001
  Speech and language therapist (SLT) 2,785 (6.7) 8807 (21.2) <.001
  Psychologist 1214 (2.9) 2377 (5.7) <.001
  Kinesiologist 1562 (3.8) 4311 (10.4) <.001
  Occupational therapist 658 (1.6) 1546 (3.7) <.001
  Stakeholder group 941 (2.3) 3038 (7.3) <.001
  1. *McNemar test